{"id":"W2925046483","doi":"10.1080/21645515.2019.1591139","title":"A product review of vedolizumab in inflammatory bowel disease","year":2019,"lang":"en","type":"review","venue":"Human Vaccines & Immunotherapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Addressin; Inflammatory bowel disease; Ulcerative colitis; Pharmacodynamics; Crohn's disease; Ustekinumab; Pharmacology; Immunology; Internal medicine; Tumor necrosis factor alpha; Infliximab; Disease; Pharmacokinetics; Integrin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004715125,0.0007956552,0.001093338,0.002725064,0.0002707895,0.0009536253,0.0006523525,0.0009197202,0.008425836],"category_scores_gemma":[0.0007770971,0.0002585354,0.0007349005,0.00253089,0.000238286,0.001007313,0.0005219312,0.001425597,0.003026205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005902022,"about_ca_system_score_gemma":0.001170254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001083027,"about_ca_topic_score_gemma":0.002020831,"domain_scores_codex":[0.9998048,0.00003452472,0.00003354424,0.00003113176,0.00007860192,0.00001757404],"domain_scores_gemma":[0.9996756,0.0001385759,0.00005623753,0.000006957855,0.0000899934,0.00003260514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001464045,0.00007188131,0.00009526552,0.03943537,0.0001593139,0.0001602618,0.00005377381,0.0002563385,0.001604558,0.002613257,0.09188765,0.8635159],"study_design_scores_gemma":[0.00003323828,0.00009775502,0.0004633103,0.006297166,0.0002216168,0.0005578785,0.00002195346,0.00005078239,0.0002130463,0.0006640615,0.9913682,0.00001097389],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001054435,0.9976134,0.00008240814,0.0002925939,0.0005117111,0.00001017548,0.00004040151,0.000007975766,0.00133584],"genre_scores_gemma":[0.0004714489,0.9973787,0.0001804587,0.0003484495,0.0002782456,0.00001299752,0.00006994417,0.000002032757,0.00125772],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008425836,"threshold_uncertainty_score":0.02818722,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03251273264421737,"score_gpt":0.3283188723708608,"score_spread":0.2958061397266434,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}